View in EDS

Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Saved in:
Bibliographic Details
Title: Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.
Authors: Talpin A; Enterome, Paris, Île-de-France, France., Maia A; Institute for Immunology and Cluster of Excellence iFIT (EXC2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard-Karls-University Tübingen, Tübingen, Germany., Carpier JM; Enterome, Paris, Île-de-France, France., Kulakowski G; Enterome, Paris, Île-de-France, France., Aubergeon L; Enterome, Paris, Île-de-France, France., Kervevan J; Enterome, Paris, Île-de-France, France., Gaal C; Enterome, Paris, Île-de-France, France., Strozzi F; Enterome, Paris, Île-de-France, France., Billerey C; Enterome, Paris, Île-de-France, France., Amable L; Enterome, Paris, Île-de-France, France., Mersceman T; Enterome, Paris, Île-de-France, France., Garnier A; Enterome, Paris, Île-de-France, France., Oliveira C; Enterome, Paris, Île-de-France, France., Calderon C; Enterome, Paris, Île-de-France, France., Bachrouche D; Enterome, Paris, Île-de-France, France., Ventujol C; Enterome, Paris, Île-de-France, France., Bernard L; Enterome, Paris, Île-de-France, France., Manteau A; Enterome, Paris, Île-de-France, France., Martinez J; Enterome, Paris, Île-de-France, France., Bonnet M; Enterome, Paris, Île-de-France, France., Noguerol J; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France., Laviolette K; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France., Boullerot L; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France., Malfroy M; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France., Chevalier G; Enterome, Paris, Île-de-France, France., Adotevi O; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France., Joffre O; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France., Idbaih A; Sorbonne Université, AP-HP, ICM, Hôpital Universitaire La Pitié-Salpêtrière, Paris, France., Vieito M; Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain., Ghiringhelli F; UMR 1231, Centre Georges-Francois Leclerc, Dijon, Bourgogne-Franche-Comté, France., Stradella A; Institut Catala D'Oncologia - Hospital Duran i Reynals, Barcelona, Spain., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Stuttgart, Germany., Burger MC; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany., Mildenberger I; Universitat Heidelberg Medizinische Fakultat Mannheim, Mannheim, Baden-Württemberg, Germany., Herrlinger U; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany., Reardon DA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wick W; Universitätsklinikum Heidelberg and German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany., Gouttefangeas C; Institute for Immunology and Cluster of Excellence iFIT (EXC2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard-Karls-University Tübingen, Tübingen, Germany., Bonny C; Enterome, Paris, Île-de-France, France., Chene L; Enterome, Paris, Île-de-France, France., Gamelas Magalhaes J; Enterome, Paris, Île-de-France, France jmagalhaes@enterome.com.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Feb 20; Vol. 13 (2). Date of Electronic Publication: 2025 Feb 20.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39979071
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Talpin+A%22">Talpin A</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Maia+A%22">Maia A</searchLink>; Institute for Immunology and Cluster of Excellence iFIT (EXC2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard-Karls-University Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Carpier+JM%22">Carpier JM</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Kulakowski+G%22">Kulakowski G</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Aubergeon+L%22">Aubergeon L</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Kervevan+J%22">Kervevan J</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Gaal+C%22">Gaal C</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Strozzi+F%22">Strozzi F</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Billerey+C%22">Billerey C</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Amable+L%22">Amable L</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Mersceman+T%22">Mersceman T</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Garnier+A%22">Garnier A</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Oliveira+C%22">Oliveira C</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Calderon+C%22">Calderon C</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Bachrouche+D%22">Bachrouche D</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Ventujol+C%22">Ventujol C</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Bernard+L%22">Bernard L</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Manteau+A%22">Manteau A</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Martinez+J%22">Martinez J</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Bonnet+M%22">Bonnet M</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Noguerol+J%22">Noguerol J</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Laviolette+K%22">Laviolette K</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Boullerot+L%22">Boullerot L</searchLink>; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France.<br /><searchLink fieldCode="AU" term="%22Malfroy+M%22">Malfroy M</searchLink>; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France.<br /><searchLink fieldCode="AU" term="%22Chevalier+G%22">Chevalier G</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Adotevi+O%22">Adotevi O</searchLink>; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France.<br /><searchLink fieldCode="AU" term="%22Joffre+O%22">Joffre O</searchLink>; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Idbaih+A%22">Idbaih A</searchLink>; Sorbonne Université, AP-HP, ICM, Hôpital Universitaire La Pitié-Salpêtrière, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vieito+M%22">Vieito M</searchLink>; Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain.<br /><searchLink fieldCode="AU" term="%22Ghiringhelli+F%22">Ghiringhelli F</searchLink>; UMR 1231, Centre Georges-Francois Leclerc, Dijon, Bourgogne-Franche-Comté, France.<br /><searchLink fieldCode="AU" term="%22Stradella+A%22">Stradella A</searchLink>; Institut Catala D'Oncologia - Hospital Duran i Reynals, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Tabatabai+G%22">Tabatabai G</searchLink>; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Stuttgart, Germany.<br /><searchLink fieldCode="AU" term="%22Burger+MC%22">Burger MC</searchLink>; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Mildenberger+I%22">Mildenberger I</searchLink>; Universitat Heidelberg Medizinische Fakultat Mannheim, Mannheim, Baden-Württemberg, Germany.<br /><searchLink fieldCode="AU" term="%22Herrlinger+U%22">Herrlinger U</searchLink>; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany.<br /><searchLink fieldCode="AU" term="%22Reardon+DA%22">Reardon DA</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Wick+W%22">Wick W</searchLink>; Universitätsklinikum Heidelberg and German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany.<br /><searchLink fieldCode="AU" term="%22Gouttefangeas+C%22">Gouttefangeas C</searchLink>; Institute for Immunology and Cluster of Excellence iFIT (EXC2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard-Karls-University Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Bonny+C%22">Bonny C</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Chene+L%22">Chene L</searchLink>; Enterome, Paris, Île-de-France, France.<br /><searchLink fieldCode="AU" term="%22Gamelas+Magalhaes+J%22">Gamelas Magalhaes J</searchLink>; Enterome, Paris, Île-de-France, France jmagalhaes@enterome.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Feb 20; Vol. 13 (2). <i>Date of Electronic Publication: </i>2025 Feb 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39979071
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-010192
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Talpin A
      – PersonEntity:
          Name:
            NameFull: Maia A
      – PersonEntity:
          Name:
            NameFull: Carpier JM
      – PersonEntity:
          Name:
            NameFull: Kulakowski G
      – PersonEntity:
          Name:
            NameFull: Aubergeon L
      – PersonEntity:
          Name:
            NameFull: Kervevan J
      – PersonEntity:
          Name:
            NameFull: Gaal C
      – PersonEntity:
          Name:
            NameFull: Strozzi F
      – PersonEntity:
          Name:
            NameFull: Billerey C
      – PersonEntity:
          Name:
            NameFull: Amable L
      – PersonEntity:
          Name:
            NameFull: Mersceman T
      – PersonEntity:
          Name:
            NameFull: Garnier A
      – PersonEntity:
          Name:
            NameFull: Oliveira C
      – PersonEntity:
          Name:
            NameFull: Calderon C
      – PersonEntity:
          Name:
            NameFull: Bachrouche D
      – PersonEntity:
          Name:
            NameFull: Ventujol C
      – PersonEntity:
          Name:
            NameFull: Bernard L
      – PersonEntity:
          Name:
            NameFull: Manteau A
      – PersonEntity:
          Name:
            NameFull: Martinez J
      – PersonEntity:
          Name:
            NameFull: Bonnet M
      – PersonEntity:
          Name:
            NameFull: Noguerol J
      – PersonEntity:
          Name:
            NameFull: Laviolette K
      – PersonEntity:
          Name:
            NameFull: Boullerot L
      – PersonEntity:
          Name:
            NameFull: Malfroy M
      – PersonEntity:
          Name:
            NameFull: Chevalier G
      – PersonEntity:
          Name:
            NameFull: Adotevi O
      – PersonEntity:
          Name:
            NameFull: Joffre O
      – PersonEntity:
          Name:
            NameFull: Idbaih A
      – PersonEntity:
          Name:
            NameFull: Vieito M
      – PersonEntity:
          Name:
            NameFull: Ghiringhelli F
      – PersonEntity:
          Name:
            NameFull: Stradella A
      – PersonEntity:
          Name:
            NameFull: Tabatabai G
      – PersonEntity:
          Name:
            NameFull: Burger MC
      – PersonEntity:
          Name:
            NameFull: Mildenberger I
      – PersonEntity:
          Name:
            NameFull: Herrlinger U
      – PersonEntity:
          Name:
            NameFull: Reardon DA
      – PersonEntity:
          Name:
            NameFull: Wick W
      – PersonEntity:
          Name:
            NameFull: Gouttefangeas C
      – PersonEntity:
          Name:
            NameFull: Bonny C
      – PersonEntity:
          Name:
            NameFull: Chene L
      – PersonEntity:
          Name:
            NameFull: Gamelas Magalhaes J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2025 Feb 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1